Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175835
Max Phase: Preclinical
Molecular Formula: C31H38N2O7
Molecular Weight: 550.65
Associated Items:
ID: ALA5175835
Max Phase: Preclinical
Molecular Formula: C31H38N2O7
Molecular Weight: 550.65
Associated Items:
Canonical SMILES: COc1cc(OCc2cccc(-c3ccc4c(c3)OCCO4)c2C)cc(OC)c1CNCCCCCC(=O)NO
Standard InChI: InChI=1S/C31H38N2O7/c1-21-23(8-7-9-25(21)22-11-12-27-30(16-22)39-15-14-38-27)20-40-24-17-28(36-2)26(29(18-24)37-3)19-32-13-6-4-5-10-31(34)33-35/h7-9,11-12,16-18,32,35H,4-6,10,13-15,19-20H2,1-3H3,(H,33,34)
Standard InChI Key: HLHOQKZAIDITCS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 550.65 | Molecular Weight (Monoisotopic): 550.2679 | AlogP: 5.18 | #Rotatable Bonds: 14 |
Polar Surface Area: 107.51 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.91 | CX Basic pKa: 8.29 | CX LogP: 4.10 | CX LogD: 3.49 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.14 | Np Likeness Score: -0.31 |
1. Xu X, Zhang D, Zhao T, Wang M, Li Y, Du Q, Kou J, Li Z, Bian J.. (2022) Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation., 233 [PMID:35245830] [10.1016/j.ejmech.2022.114228] |
Source(1):